Anupam Rasayan Q2 Earnings Explained: Margin Pressure, Pharma Growth & FY27 Outlook | ET Now　 #ETNOW

Anupam Rasayan delivers a stellar Q2 with revenue up 2.5x and PAT rising 84%, but margins see pressure at 18.6%. Deputy CFO Vishal Thakkar breaks down the numbers, reasons for margin compression, outlook for a 24–26% EBITDA rebound, and strong growth from pharma & polymer segments. Tune in as ET NOW discusses CapEx, working capital discipline, and the roadmap to ₹3,000 crore turnover by FY27.

#etnow #q2earnings #anupamrasayan #q2result #topnews #businessnews #stockmarket #pharmasector

YouTube Channel – https://www.youtube.com/@ETNow

Subscribe To ET Now For Latest Updates On Stocks Market News , Business News, Company News, IPO & More | https://bit.ly/SubscribeToETNow

Subscribe Now To Our Network Channels :-
ET Now Swadesh: https://www.youtube.com/etnowswadesh
Times Now: http://goo.gl/U9ibPb

Social Media Links :-
Twitter – http://goo.gl/hA0vDt
Facebook – http://goo.gl/5Lr4mC

Website – https://ift.tt/WdxqRm3